Shahid A Khan
Overview
Explore the profile of Shahid A Khan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
5815
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan S, Rushbrook S, Kendall T, Zen Y, Albazaz R, Manoharan P, et al.
Gut
. 2024 Aug;
74(3):504-505.
PMID: 39160057
No abstract available.
2.
Tataru D, Khan S, Hill R, Morement H, Wong K, Paley L, et al.
JHEP Rep
. 2024 Feb;
6(3):100983.
PMID: 38357420
Background & Aims: While cholangiocarcinoma (CCA) incidence and mortality rates are increasing globally, whether there are regional/temporal variations in these rates for different biliary tract cancer (BTC) subtypes, or whether...
3.
Jose S, Zalin-Miller A, Knott C, Paley L, Tataru D, Morement H, et al.
World J Gastrointest Oncol
. 2024 Jan;
15(12):2077-2092.
PMID: 38173436
Background: Outcomes for cholangiocarcinoma (CCA) are extremely poor owing to the complexities in diagnosing and managing a rare disease with heterogenous sub-types. Beyond curative surgery, which is only an option...
4.
Rushbrook S, Kendall T, Zen Y, Albazaz R, Manoharan P, Pereira S, et al.
Gut
. 2023 Sep;
73(1):16-46.
PMID: 37770126
These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included a multidisciplinary team of experts...
5.
Qurashi M, Vithayathil M, Khan S
Eur J Surg Oncol
. 2023 Sep;
51(2):107064.
PMID: 37709624
Cholangiocarcinoma (CCA) represents a heterogenous set of malignancies arising from the biliary tract. Classification of CCA subdivides tumours into intrahepatic (iCCA) and extrahepatic (eCCA), with eCCA further categorised as perihilar...
6.
Khuntikeo N, Andrews R, Petney T, Khan S
Recent Results Cancer Res
. 2023 Sep;
219:361-367.
PMID: 37660340
Cholangiocarcinoma (CCA) is the second most common primary liver cancer worldwide. Despite the severity of the disease and its impact on individuals, families, and communities, there remains an overall lack...
7.
Khuntikeo N, Andrews R, Petney T, Khan S
Recent Results Cancer Res
. 2023 Sep;
219:1-5.
PMID: 37660328
Cholangiocarcinoma (CCA) is a lethal cancer arising in the bile ducts within and just outside the liver. It occurs worldwide and falls into two etiologically defined groups, one related to...
8.
Zalin-Miller A, Jose S, Knott C, Paley L, Tataru D, Morement H, et al.
World J Gastroenterol
. 2023 Jul;
29(24):3825-3842.
PMID: 37426314
Background: Incidence of cholangiocarcinoma (CCA) is rising, with overall prognosis re-maining very poor. Reasons for the high mortality of CCA include its late presentation in most patients, when curative options...
9.
Scott R, Cross T, Clarke C, Khan S, Ryder S, Franklin J, et al.
J Hepatocell Carcinoma
. 2023 May;
10:725-731.
PMID: 37152438
Background & Aim: HCC has significantly improved outcomes when detected early. Guidelines recommend biannual surveillance with ultrasound (US) and/or AFP in at-risk individuals. This survey aimed to describe HCC surveillance...
10.
Vithayathil M, Khan S
J Hepatol
. 2022 Aug;
77(6):1690-1698.
PMID: 35977611
Cholangiocarcinomas are cancers arising from bile ducts, either found within the liver (intrahepatic) or outside the liver (extrahepatic). In Western countries, deaths due to intrahepatic cancers are rising at a...